Annals of internal medicine
-
Multicenter Study Clinical Trial
Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin.
To evaluate the effects of long-term-intravenous infusion of prostacyclin on exercise capacity, hemodynamics, and survival in patients with primary pulmonary hypertension. ⋯ Continuous intravenous prostacyclin resulted in sustained clinical and hemodynamic improvement and probably in improved survival in patients with severe primary pulmonary hypertension. Despite potentially serious complications, long-term prostacyclin may be especially helpful in seriously ill patients awaiting transplantation.
-
Comment Letter
Diagnosing pheochromocytoma in von Hippel-Lindau disease.